Antibody, T-cell and dendritic cell immunotherapy for malignant brain tumors
about
Overview of current immunotherapeutic strategies for gliomaSevere adverse immunologic reaction in a patient with glioblastoma receiving autologous dendritic cell vaccines combined with GM-CSF and dose-intensified temozolomide.Recent advances and future of immunotherapy for glioblastoma.Polymersomes and their applications in cancer delivery and therapy.Current update of adoptive immunotherapy using cytokine-induced killer cells to eliminate malignant gliomas.Artificial human antigen-presenting cells are superior to dendritic cells at inducing cytotoxic T-cell responses.Ex vivo generation of dendritic cells from cryopreserved, post-induction chemotherapy, mobilized leukapheresis from pediatric patients with medulloblastoma.A novel recombinant immunotoxin-based therapy targeting wild-type and mutant EGFR improves survival in murine models of glioblastomaChimeric antigen receptor engineered T cells can eliminate brain tumors and initiate long-term protection against recurrence.Current state and future prospects of immunotherapy for glioma.
P2860
Q26776345-50A2B194-1269-4E02-A818-BDCA67D2FCAFQ35878166-E95B03A3-2F91-476B-BEF3-F1B4D311F1F9Q37239071-945407C7-B0CD-44D2-82F7-90CEA85B55FCQ38578305-D66FE9A9-C38F-4C49-AF6E-2B8EECC47EFCQ39208487-F378CC9E-450C-4C22-AD65-EF38400A1A0FQ40140002-244DB13E-CB85-40B8-B60E-9F3D0FC72AD1Q41391698-54EF74E0-7881-4B0D-A30B-57639B040265Q41841115-950F6C22-190A-46AF-90F1-7A5D0269402BQ42057942-7DA05C88-7B4E-4A43-97BC-E2F8145E7583Q50109459-C527EA24-41FA-4369-B3B9-6B6F50A63254
P2860
Antibody, T-cell and dendritic cell immunotherapy for malignant brain tumors
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Antibody, T-cell and dendritic cell immunotherapy for malignant brain tumors
@ast
Antibody, T-cell and dendritic cell immunotherapy for malignant brain tumors
@en
Antibody, T-cell and dendritic cell immunotherapy for malignant brain tumors
@nl
type
label
Antibody, T-cell and dendritic cell immunotherapy for malignant brain tumors
@ast
Antibody, T-cell and dendritic cell immunotherapy for malignant brain tumors
@en
Antibody, T-cell and dendritic cell immunotherapy for malignant brain tumors
@nl
prefLabel
Antibody, T-cell and dendritic cell immunotherapy for malignant brain tumors
@ast
Antibody, T-cell and dendritic cell immunotherapy for malignant brain tumors
@en
Antibody, T-cell and dendritic cell immunotherapy for malignant brain tumors
@nl
P2093
P2860
P921
P356
P1433
P1476
Antibody, T-cell and dendritic cell immunotherapy for malignant brain tumors
@en
P2093
Duane A Mitchell
John H Sampson
Laura A Johnson
Vidyalakshmi Chandramohan
P2860
P304
P356
10.2217/FON.13.47
P407
P577
2013-07-01T00:00:00Z